During the past decade, Osaka Medical College Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 9 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Osaka Medical College Hospital" #1 sponsor was "Osaka Medical College" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 3 trials sponsored, "Bayer" with 2 trials sponsored and "Galapagos NV" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Osaka Medical College Hospital" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 2 trials as a collaborator, "Tokyo Medical and Dental University" with 2 trials as a collaborator, "Canadian VIGOUR Centre" with 1 trials as a collaborator and "Department of Nuerosurgery, Osaka Medical College" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Osaka Medical College Hospital" are "Colorectal Cancer" (6 trials), "Breast Cancer" (2 trials), "EPP" (2 trials), "Gastric Cancer" (2 trials) and "HER-2 Positive Breast Cancer" (2 trials). Many other conditions were trialed in "Osaka Medical College Hospital" in a lesser frequency.

Most popular intervention types in "Osaka Medical College Hospital" are "Drug" (25 trials), "Biological" (5 trials), "Other" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Filgotinib" (3 trials), "ACC-001" (2 trials), "UFT adjuvant chemotherapy" (2 trials) and "cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Osaka Medical College Hospital" are 24 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Osaka Medical College Hospital". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Osaka Medical College Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Osaka Medical College Hospital, 1 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Osaka Medical College Hospital has several departments that took part in Clinical trials: "Osaka Medical College Hospital" - 7 trials